TLR Agonists as Vaccine Adjuvants Targeting Cancer and Infectious Diseases

Modern vaccines have largely shifted from using whole, killed or attenuated pathogens to being based on subunit components. Since this diminishes immunogenicity, vaccine adjuvants that enhance the immune response to purified antigens are critically needed. Further advantages of adjuvants include dos...

Descripción completa

Detalles Bibliográficos
Autores principales: Luchner, Marina, Reinke, Sören, Milicic, Anita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7911620/
https://www.ncbi.nlm.nih.gov/pubmed/33499143
http://dx.doi.org/10.3390/pharmaceutics13020142

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7911620/
https://www.ncbi.nlm.nih.gov/pubmed/33499143
http://dx.doi.org/10.3390/pharmaceutics13020142

Ejemplares similares